MyMelanoma study

MyMelanoma aim to build the biggest melanoma data resource ever collected in the UK.

This will enable researchers to answer key unanswered questions about melanoma, for example, how different diet and lifestyle factors may affect the risk of cancer and why some people experience side-effects to certain treatments. Anyone in the UK who has been treated for a melanoma arising from the skin, genitalia, nail web or mucosal surface, by the NHS is eligible to participate in MyMelanoma. 

NHS England has been asked to identify people who may be eligible and to invite them to join the MyMelanoma study. We will use the data we hold to identify potentially suitable people and send them an invitation to take part. The data used will include name and address. Your personal data will not be shared directly with the research study team.

To manage the invitation process, we will need to keep the list of people who have been invited until six months after the research study recruitment is complete. This is to ensure that you are not invited if you have told us you do not want to be contacted.

After this time, all the information stored for the purpose of this research programme will be deleted. You can find out more about your choices on how the NHS uses your data for research and planning.

We will use your data to produce summary reports to monitor recruitment into the research study (for example how many people were invited). These reports will not identify you personally.

As an executive non-departmental body reporting to the Department of Health and Social Care most of our processing activity is directed by the Secretary of State for Health and Social Care. NHS England is Directed under the pilot NHS DigiTrials recruitment support services directions 2021 to process data to identify potentially eligible participants to take part in the research study.

Additionally, the Health Research Authority has provided legal support to the MyMelanoma study under Section 251 of the NHS Act 2006 and Regulation 5 of The Health Service (Control of Patient Information) Regulations 2002 which enable the common law duty of confidentiality to be temporarily lifted so that confidential patient information can be processed by NHS England on behalf of the research study. This support provides the legal basis for suitable participants to be invited to join the research study. This is following advice from the Confidentiality Advisory Group, an advisory body which provides independent expert advice on the use of confidential patient information without consent in England and Wales.

If you have requested that your NHS data is not shared for research and planning purposes (by registering a National Data Opt-out) then you will not receive an invitation for this research study.

To read more about the health and care information NHS England collects, our legal basis for collecting this information and what choices and rights you have, see How we look after your health and care information and our general transparency notice and the related GDPR register entry.

If you do not want to be invited by NHS England to take part in the MyMelanoma study, complete our online opt-out form using the button below, or call the team on 01865 617 043. 

The team will complete the form on the NHS England website on your behalf and will not record your details in the MyMelanoma database.

In the future you may be approached by other organisations to join the MyMelanoma study, but NHS England will not invite you. You will always be able to choose if you wish to volunteer.

NHS England processes and holds the opt-out list on behalf of the MyMelanoma study. 

If you have previously opted out of sharing your health data for planning and research purposes by submitting a national data opt-out, you do not need to take any action. You will not be invited to take part in this challenge study by NHS England.